These courses are intended for internal hospital staff.

Activity Description:

This series will review data on complex pediatric cases that are reviewed by the attending staff of the pediatric, cardiology and cardiac surgery teams. The content of the series will focus on the best practices in management of patients for pediatric congenital cardiac surgery or catheterization lab intervention. Communicate best practices to improve the quality, safety diagnosis and treatment for complex pediatric cases. Discuss diagnostic, therapeutic and dilemmas that are presented each week. These discussions and analysis of cases contribute to establish and propose more effective guidelines in pediatric patient care.

Target Audience:

Pediatric Physicians, General Surgeons, Pediatric Surgeons, Pathologists, Radiologists, Pharmacists, Nurses  

Learning Objectives:

At the conclusion of this Regularly Scheduled Series, participants should be able to:

1. Effectively participate in the clinical management of patients with heart disease
2. Interpret data and utilize interpretation in medical decision making
3. Decide between surgical options for patients with heart disease

Moderator:

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

Accreditation:

The HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Credit Designation:

The HCA Healthcare Continental Division designates this live activity for a maximum of 1.0 AMA PRA Category 1^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support:  

This Activity was developed without support from any ineligible company.*The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.

Disclosure: 

The HCA Healthcare Continental Division is committed to providing CME that is balanced, objective, and evidenced-based. In accordance with the Accreditation Council for Continuing Medical Education Standards for Integrity and Independence all parties involved in content development are required to disclose all conflicts of interest with ACCME defined ineligible companies. The HCA Healthcare Continental Division has identified, reviewed, and mitigated all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity. The CME planning committee who are in a position to control the content of this CME Activity, have no relevant financial relationships with ineligible companies to disclose.